Substitution p.A350V in Na⁺/Mg²⁺ exchanger SLC41A1, potentially associated with Parkinson's disease, is a gain-of-function mutation.
Parkinson's disease (PD) is a complex multifactorial ailment predetermined by the interplay of various environmental and genetic factors. Systemic and intracellular magnesium (Mg) deficiency has long been suspected to contribute to the development and progress of PD and other neurodegenerative...
Guardado en:
Autores principales: | Martin Kolisek, Gerhard Sponder, Lucia Mastrototaro, Alina Smorodchenko, Pierre Launay, Juergen Vormann, Monika Schweigel-Röntgen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9c25ce6601934adb8d9216c4ffea8bf7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
SLC41A3 Exhibits as a Carcinoma Biomarker and Promoter in Liver Hepatocellular Carcinoma
por: Qimeng Chang, et al.
Publicado: (2021) -
Acta Nº350
por: Banco Central de Chile
Publicado: (2019) -
Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA/SCID mice.
por: Nicolas Brezillon, et al.
Publicado: (2011) -
Cardiothoracic CTA in Infants Referred for Aortic Arch Evaluation—Retrospective Comparison of Iomeprol 350, Ioversol 350, Iopromide 370 and Iodixanol 320
por: Marian Pop
Publicado: (2021) -
Advanced Mg, Zn, Sr, Si Multi-Substituted Hydroxyapatites for Bone Regeneration
por: Garbo C, et al.
Publicado: (2020)